Amgen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. 

CEO
Robert A. Bradway
CEORobert A. Bradway
Employees
31,500
Employees31,500
Headquarters
Thousand Oaks, California
HeadquartersThousand Oaks, California
Founded
1980
Founded1980
Employees
31,500
Employees31,500

AMGN Key Statistics

Market cap
248.91B
Market cap248.91B
Price-Earnings ratio
26.70
Price-Earnings ratio26.70
Dividend yield
2.16%
Dividend yield2.16%
Average volume
2.99M
Average volume2.99M
High today
$462.91
High today$462.91
Low today
$446.37
Low today$446.37
Open price
$446.45
Open price$446.45
Volume
2.58M
Volume2.58M
52 Week high
$483.99
52 Week high$483.99
52 Week low
$312.39
52 Week low$312.39

Stock Snapshot

As of today, Amgen(AMGN) shares are valued at $459.53. The company's market cap stands at 248.91B, with a P/E ratio of 26.70 and a dividend yield of 2.16%.

On 2026-11-07, Amgen(AMGN) stock moved within a range of $446.37 to $462.91. With shares now at $459.53, the stock is trading +2.9% above its intraday low and -0.7% below the session's peak.

Trading activity shows a volume of 2.58M, compared to an average daily volume of 2.99M.

Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $483.99 and a low of $312.39.

Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $483.99 and a low of $312.39.

AMGN News

Simply Wall St 4h
Amgen Stock Could Be 34% Below Fair Value Following Raised Guidance

has been a strong performer in large-cap biotech, and with the stock recently around US$460 per share the key question for you is how well that price lines up w...

Amgen Stock Could Be 34% Below Fair Value Following Raised Guidance
The Motley Fool 2d
Amgen vs. Pfizer: Which Healthcare Stock Is a Better Buy for 2027?

Can a growth-oriented biotech giant outpace a value-leaning pharmaceutical titan? Choosing between Amgen Inc. (AMGN -0.79%) and Pfizer Inc. (PFE +0.93%) require...

Amgen vs. Pfizer: Which Healthcare Stock Is a Better Buy for 2027?
Investor's Business Daily 2d
Cardinal Health Deepens Its Grip On The Buy Zone On Street-Beating Guidance

Dow Jones Biotech Giant Amgen Breaks Out Ahead Of Q3 Earnings Results 10/27/2026 Dow Jones biotech giant Amgen stock is trying to break out past a new buy poin...

Cardinal Health Deepens Its Grip On The Buy Zone On Street-Beating Guidance

Analyst ratings

54%

of 37 ratings
Buy
29.7%
Hold
54.1%
Sell
16.2%

More AMGN News

TipRanks 3d
Amgen Earnings Call Highlights Growth, Pipeline Momentum

Amgen Inc ((AMGN)) has held its Q3 earnings call. Read on for the main highlights of the call. Amgen’s third-quarter call carried a strongly optimistic tone, w...

Benzinga 3d
Amgen Analyst Likes Diversified Business, Remains Patient Until MariTide Obesity Data

Amgen Inc. (NASDAQ:AMGN) shares are trading close to its 52-week high on Wednesday after the company reported better-than-expected third-quarter financial resul...

Amgen Analyst Likes Diversified Business, Remains Patient Until MariTide Obesity Data
Zacks 3d
AMGN Stock Down Despite Q3 Earnings & Sales Beat, Raised Guidance

Amgen (AMGN Quick QuoteAMGN - Free Report) reported third-quarter 2026 adjusted earnings of $6.45 per share, up 14% year over year, driven primarily by hi...

AMGN Stock Down Despite Q3 Earnings & Sales Beat, Raised Guidance
Zacks 4d
Amgen Reports Q3 Earnings: What Key Metrics Have to Say

For the quarter ended September 2026, Amgen (AMGN Quick QuoteAMGN - Free Report) reported revenue of $10.37 billion, up 8.5% over the same period last yea...

Amgen Reports Q3 Earnings: What Key Metrics Have to Say
Zacks 4d
Amgen Tops Q3 Earnings and Revenue Estimates

Amgen (AMGN Quick QuoteAMGN - Free Report) came out with quarterly earnings of $6.45 per share, beating the Zacks Consensus Estimate of $5.74 per share. T...

Amgen Tops Q3 Earnings and Revenue Estimates
Simply Wall St 4d
Amgen Forms Rare Autoimmune Disease Diagnosis Collaboration

Amgen (NasdaqGS:AMGN) and the National Organization for Rare Disorders formed a rare autoimmune disease diagnosis Learning Collaborative involving multiple inst...

Amgen Forms Rare Autoimmune Disease Diagnosis Collaboration
Seeking Alpha 5d
Amgen Q3 preview: What to expect

Analysts will be keenly tracking the top-line performance of Amgen’s (AMGN) established products, as they continue to see revenue erosion, when the firm reports...

Amgen Q3 preview: What to expect

People also own

Based on the portfolios of people who own AMGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.